Phylogenetic Analysis and Structural Evaluation of Staphylococcus aureus Serine-Aspartate Repeat-Containing Protein D

Kemin Tan1,2, Kathleen A O'Connor3, Xiaobing Zuo4

  • 1Center for Structural Biology of Infectious Diseases, University of Chicago, Chicago, Illinois, USA.

Insights

This study characterized the SdrD protein in Staphylococcus aureus periprosthetic joint infections (PJI), revealing genetic diversity and a surprisingly rigid structure. Findings challenge previous binding mechanisms and may guide new anti-adhesion strategies for PJI.

Area of Science:

  • Microbiology
  • Structural Biology
  • Infectious Diseases

Background:

  • Staphylococcus aureus is a leading cause of periprosthetic joint infection (PJI).
  • The SdrD adhesin contributes to S. aureus virulence and adhesion but its diversity and binding mechanism in PJI are poorly understood.

Purpose of the Study:

  • To characterize the population-level distribution and sequence diversity of SdrD in clinical PJI isolates.
  • To elucidate the SdrD binding mechanism through structural and dynamic analyses.

Main Methods:

  • Bioinformatic analysis of sdrD alleles across clinical PJI and public S. aureus genomes.
  • Phylogenetic analysis of the sdrCDE locus.
  • Determination of SdrD crystal structure.
  • Solution small-angle X-ray scattering (SAXS) and molecular dynamics (MD) simulations.

Main Results:

  • Three dominant sdrD subtypes were identified, with one being predominant in PJI isolates.
  • Structural studies revealed limited flexibility in SdrD's domain conformation and interdomain organization.
  • The calcium-binding B domain maintained its fold under calcium depletion, contrary to previous assumptions.

Conclusions:

  • SdrD exhibits significant genetic diversity among PJI isolates, with specific subtypes being more prevalent.
  • SdrD possesses a relatively rigid structure, necessitating a re-evaluation of its previously proposed ligand-binding mechanism.
  • These findings may inform the development of novel strategies to prevent S. aureus adhesion and PJI.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased by a...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...